Edge
StocktwitsEarnings

Official STOCKTWITS Representative
$TEVA Q2 '26 Earnings Results & Recap
• Reported GAAP EPS of -$0.49 down -296.00% YoY
• Reported revenue of $4.14B down -0.81% YoY
• Teva Pharmaceutical Industries Ltd. expects 2026 revenue of $16.5-$16.85 billion, non-GAAP operating income of $3.8-$4.0 billion, and non-GAAP diluted EPS of $1.91-$2.11, while maintaining its free cash flow outlook.1
